Skip to content
RDL Network logo
O-094 Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable Non-small cell lung cancer (NSCLC) — P. Kosmidis (2005) | RDL Network